Text or WhatsApp Richard at (808) 600-9260
Lion crestHealthcareInvestmentBanking.com

Preparing a Healthcare Company for Sale: Fix What Buyers Will Find Before They Find It

To prepare a healthcare company for sale, run the buyer's diligence on yourself before you sign an LOI. Rebuild EBITDA the way a buyer will, with market-rate physician pay. Commission an independent coding review. List every financial arrangement with a referral source. Settle the tax structure, model net proceeds and map the regulatory timeline back from closing. An issue you find first is one you can fix, price or disclose on your terms. An issue the buyer finds after you sign an LOI is priced by the buyer, under exclusivity, with no competing bid to check it.

Data as of November 20, 2026. PESP figures (reported by Becker's ASC Review), FOCUS Investment Banking figures and SRS Acquiom figures cover calendar 2025 deals. Kaufman Hall hospital counts run through Q3 2026. CMS spending figures cover calendar 2024, with projections for 2025 through 2034. Every worked example uses one hypothetical physician group so the numbers reconcile from section to section. All derived numbers are our arithmetic, with the assumptions stated. Market figures each come from a single source, including advisory firm and vendor reports, and have not been independently verified. Check the linked source before relying on any figure.

Sale-Readiness Checklist: Ten Steps in Priority Order

The items at the top move price the most, or a price cut cannot fix them once a buyer finds them. Finish steps 1 to 3 before you talk to any buyer. The full working version is the sell-side readiness checklist.

Priority Step Why it ranks here Output
1 Rebuild EBITDA on a buyer basis Post-sale physician pay is often the largest single adjustment, and the multiple applies to every dollar of it Buyer-basis EBITDA model with workpapers
2 Independent coding review Buyers test coding and treat unsupported billing as a liability against the price Findings, corrective action, refund log
3 Inventory every financial relationship with a referral source Some referral problems cannot be cured by lowering the price Arrangements list and red-flag list
4 Review the ownership and MSO structure Structure shapes what the buyer can own and how Structure memo
5 Fill in missing or understated costs A buyer adds any cost your statements leave out, such as malpractice coverage or market rent Complete expense lines
6 Move founder-held relationships to other people Buyers discount revenue that depends on one person A named owner for each payer and referral relationship
7 Settle deal structure and tax Asset versus equity and price allocation decide what you keep after tax Structure decision and after-tax proceeds model
8 Map federal and state transaction notices Waiting periods can set your closing date Filing map with dates
9 Plan Medicare, Medicaid and payer enrollment changes Enrollment gaps delay collections after closing Enrollment and payer notice plan
10 Build the data room, then reset the asking price to buyer-basis EBITDA A price you cannot defend in diligence comes down after exclusivity Indexed data room and a defensible price

Decision rule: if step 2 or step 3 turns up something that may need repayment or disclosure, resolve it before marketing, or at least decide how you will disclose it. If the buyer's accountant finds it first, the buyer sets the terms.

Fix, Price or Disclose: A Decision Table for Findings

Every finding from your own review lands in one of four buckets. Decide which before a buyer sees it.

Finding type Example Best response before marketing What happens if the buyer finds it first
Fixable at low cost Expired lease with a physician landlord, missing medical director time logs Fix it now and document the fix Special indemnity or a closing condition
Quantifiable Coding errors in one provider's E/M levels, understated malpractice expense Quantify it, process refunds through your overpayment policy, adjust EBITDA Price cut at the buyer's estimate, which is rarely lower than yours
Structural MSO fee or control terms flagged in review, earnout tied to referral volume Restructure before going to market Deal delay, restructuring under exclusivity or a dead deal
Concentration One payer or one physician drives a large share of revenue Disclose with a retention plan and supporting data Earnout or holdback sized to the risk

Should You Sell Now or Prepare First?

Not every seller needs twelve months. The deciding question is whether the gaps you already know about would cost more in price and terms than the delay costs you.

Your situation Recommendation Reason
Accrual books, recent outside coding review, current written agreements, more than one producing physician Go to market within one quarter Preparation has diminishing returns. Use the time to build the data room
Cash-basis books, no outside coding review, owners paid through distributions Prepare for 6 to 12 months The buyer's QoE will rebuild your earnings anyway. Do it first on your terms
Known coding or arrangement problem Fix before any buyer contact Structural issues cannot be priced away once a buyer finds them
Founder produces most collections and holds every referral relationship Prepare 12 months or more, or accept an earnout-heavy offer Buyers price owner dependence through contingent payments
Health or personal timeline forces a fast sale Commission a limited QoE and coding sample, then disclose openly A disclosed issue costs less than a discovered one

Who Is Buying in 2025 and 2026

Buyers are paying for a share of a large and growing spending pool. Per the CMS National Health Expenditure fact sheet, U.S. health spending grew 7.2% to $5.3 trillion in 2024, 18.0% of GDP. Physician and clinical services spending grew 8.1% to $1,109.7 billion in 2024, and CMS projects it to grow 5.5% a year on average from 2025 through 2034. That growth is why sponsors keep building platforms in outpatient specialties.

The buyer writes the diligence list, so identify your likely buyer first. Three markets matter, and each is measured by a different dataset. The figures below describe different populations and periods and are not comparable with each other.

Private equity, outpatient care. PESP data reported by Becker's ASC Review counted 148 PE-backed outpatient care deals in calendar 2025. Of those, 119 were add-on acquisitions, about 80% by our arithmetic (119 ÷ 148 = 80.4%). If you sell an outpatient practice to a sponsor, it will most likely become an add-on to an existing platform. If you take rollover equity, your second payday depends on that sponsor's exit, so ask when it acquired the platform and when it plans to sell. A sponsor's fund-level Form D notices on SEC EDGAR full-text search show when its fund raised capital, which tells you roughly how far into its holding period the fund is.

Strategic buyers in therapeutics and technology. FOCUS Investment Banking's Healthcare EBITDA Multiples: 2026 Dashboard, a sell-side bank's review of 2025 healthcare deals, reports that strategic buyers led 86.3% of the healthcare deals it tracked, with a primary focus on therapeutics and service platform expansion. The same dashboard reports that corporate buyers in therapeutic and technology-driven sectors paid 20% to 40% higher multiples than financial sponsors on a like-for-like EBITDA basis. That is one bank's finding for those sectors. It bears on healthtech and product companies. It is not a benchmark for physician practice sales.

Hospitals and health systems. Kaufman Hall data reported by Becker's Hospital Review shows 56 announced hospital transactions through Q3 2026 (22 in Q1, 18 in Q2 and 16 in Q3), against 46 in all of 2025. The 2025 count was the lowest since Kaufman Hall began tracking in 2011. Per Kaufman Hall's Q3 2026 M&A Quarterly Activity Report, released October 13, 2026, Q3 transacted revenue reached $8.2 billion and average seller size approached $586 million in annual revenue. Not-for-profits made up most acquirers, and divestitures were nearly one-third of announced deals. This is a large-system market. For a practice or service-line owner, the relevance is that systems divesting assets and reshaping service lines also buy and sell outpatient businesses.

Most active healthcare subsectors for private equity deals, 2025 (deals)
Health IT151Dental care149Outpatient care148Medtech117Behavioral health56
Chart data
Health IT151
Dental care149
Outpatient care148
Medtech117
Behavioral health56

Source: Private Equity Stakeholder Project, PE healthcare deals 2025 in review

Chart: PESP data as reported by Becker's ASC Review, PE-backed outpatient care deals, calendar 2025.

Subsector 2025 PE-backed deal count (PESP data via Becker's ASC Review) What a buyer in this subsector will ask for
Outpatient care (all) 148 Coding, provider contracts and how fast your systems fold into a platform
Dermatology 24 Procedure mix, pathology arrangements and cash-pay cosmetic revenue
Eye care 22 Surgical volume, optical revenue, ASC ownership and comanagement arrangements
Oncology 9 Drug purchasing, infusion billing and referral relationships

Dermatology, eye care and oncology are counted within the 148 outpatient deals.

The buyer type changes what you prepare.

Buyer type Core diligence question What to have ready
PE add-on Will your coding, contracts, payroll and software fold into the platform? Clean payer contracts, system list, integration-ready HR files
PE platform Can your management team run a larger company without you? Org chart, second-layer managers, monthly reporting package
Hospital or health system How do you fit its service lines and referral network? Volume by service line, payer mix, physician alignment plan
Strategic in healthtech or services What does your product or contract base add to theirs? Recurring revenue, retention, security and patient privacy documentation
Family office or physician investor Is this a business they can hold for a long time? Plain-language Q&A, stable cash flow history, management continuity
Individual physician buyer (smaller practices) Can the cash flow service acquisition debt? Three years of tax returns, collections by provider, lender-ready statements. Many use the SBA 7(a) loan program

Outside outpatient physician care, the diligence focus shifts by sector.

Sector What the buyer tests first What to fix before marketing
Dental Hygiene and doctor production, payer fee schedules, the management services agreement Production by provider, fee schedule file, current MSA
Home health Medicare dependence, clinical documentation, licensure and survey history Survey results with plans of correction, documentation audit, enrollment records
Behavioral health Licensure, staffing ratios, clinical documentation, payer audits Licensing file by site, staffing reports, audit history
ASC Case mix, physician ownership and distributions, payer contracts Distribution formula documentation, case volume by surgeon, contract file
Health IT and services Recurring revenue, customer contracts, data security, patient data privacy terms with vendors Retention cohorts, contract summary, security assessment, BAA inventory

The healthcare M&A process guide covers how each buyer type runs a sale.

Before you sign an LOI, ask any sponsor-backed buyer:

Sell-Side Quality of Earnings Before an LOI

Institutional buyers pay an outside accounting firm to rebuild your earnings. If you have no version of your own, you first see the buyer's number after you sign an LOI, under exclusivity that bars you from talking to other buyers. A sell-side quality of earnings (QoE) report gives you the same analysis while you can still fix records, explain anomalies or reset the price. Use the QoE prep checklist to scope it.

The multiple works on every adjustment. A dollar of EBITDA you verify before marketing is multiplied into the price. A dollar the buyer's accountant strips out is multiplied against you.

Scope the engagement to cover:

Missing costs matter as much as add-backs. A surgeon who runs a surgical center carries malpractice and facility liability coverage, so a P&L without that line looks like an error or a cost paid somewhere else. If an owner pays a practice cost personally or through another entity, put the market cost into the model before a buyer does. Check insurance, related-party rent, owner vehicles and staff paid by a separate company.

The biggest swing usually comes from physician pay after closing. A practice that distributes nearly all of its cash to its owners can look profitable on a pre-compensation basis and earn far less once those owners become W-2 employees with payroll taxes and benefits.

Worked example: buyer-basis EBITDA (hypothetical group used throughout this guide, our arithmetic). A physician group collects $12,000,000 a year and earns $6,250,000 of pre-owner-compensation EBITDA, meaning earnings before interest, taxes, depreciation and amortization, measured before any pay to physician owners.

  1. Pull each physician's total take for the last full year, with distributions separated from any salary already on payroll.
  2. Set a post-sale W-2 salary for each physician and document the market support. The seller's model assumes $3,000,000 in total. The buyer's market data says $3,400,000.
  3. Add the payroll taxes and benefits that distributions never carried: $200,000.
  4. Recompute. Seller basis: $6,250,000 minus $3,000,000 equals $3,250,000. Buyer basis: $6,250,000 minus $3,400,000 minus $200,000 equals $2,650,000. The gap is $600,000.
  5. Apply a multiple to see what the gap costs. At an assumed 8.0x, chosen only to show the arithmetic, $600,000 of EBITDA equals $4,800,000 of enterprise value.
  6. Ask each physician whether they will accept buyer-basis pay. Get the answer before marketing.
  7. Put the reconciled model and workpapers in the data room so the buyer's accountant starts from your number.

Worked example: a missing cost line (same group, our arithmetic). The owners also pay a $150,000 malpractice premium through a separate entity. The buyer charges it to the practice, which takes buyer-basis EBITDA from $2,650,000 to $2,500,000. At the same assumed 8.0x, that line is worth $1,200,000 of enterprise value ($150,000 × 8.0).

Put together, the two adjustments move the defensible price a long way.

Basis EBITDA Value at assumed 8.0x
Seller basis (owner pay $3,000,000, no malpractice line) $3,250,000 $26,000,000
Buyer basis (owner pay $3,400,000, $200,000 taxes and benefits, $150,000 malpractice) $2,500,000 $20,000,000
Difference $750,000 $6,000,000

A seller who markets at $26,000,000 and gets re-traded to $20,000,000 under exclusivity loses credibility on every other number in the data room. A seller who goes to market at a defended $20,000,000 negotiates from the buyer's own method. The $20,000,000 headline price carries through every example below.

Decision rule: if buyer-basis EBITDA changes your asking price, reset the price before going to market. Then test the result against the healthcare valuation multiples guide and the practice valuation calculator.

Coding and Billing Audit Before Buyers Test It

Revenue built on codes the documentation does not support is a liability, not earnings. Buyers test coding in every healthcare deal because they cannot price what they have not measured.

Structure decides who carries that exposure. In an equity purchase, liabilities stay with the entity the buyer now owns. In an asset purchase, it depends on which liabilities the contract assumes and which enrollments transfer. Either way, the buyer's coding finding becomes your price adjustment.

Ask each prospective buyer what sample size and lookback period its coding review uses. Decide in advance what you will propose if a finding turns up: a price adjustment, a special indemnity or a cure period before signing.

A pre-sale coding review covers:

Worked example: extrapolated error (hypothetical, our arithmetic). A coder reviews 100 encounters for one provider and finds that 8 were billed one E/M level too high, with an average overpayment of $40 per affected claim. If that provider billed 6,000 government-payer E/M visits in the year, a straight-line estimate is 6,000 × 8% × $40 = $19,200. The refund is small. The pattern is not. A buyer will ask whether the same habit runs across every provider and every year in its lookback, and it will price the answer it gets.

A documented fix lands better with buyers than an issue their auditor finds. Expect the buyer or RWI insurer to respond to any known finding with an exclusion, a special indemnity or a price adjustment.

Referral Arrangements and Ownership Structure

Regulatory findings can stall a deal longer than most other issues, because some cannot be fixed with price. Buyers' counsel read every arrangement with a referring physician, and purchase price, installment payments, earnouts and post-closing pay get close review when selling physicians will keep referring to the buyer. The healthcare compliance due diligence guide explains these risk areas and how buyers test them in diligence. Take the questions it raises about your own arrangements to your own attorney.

Start with a list of every financial relationship with a referral source: employment, contractor, medical director, lease, equipment, management and consulting agreements. Then clear these red flags before the buyer opens the folder:

Red flag Why buyers react Fix before marketing
Agreement expired but payments continued Lapsed arrangements with referral sources are a standard diligence finding Renew in writing and document the gap
No fair market value support for physician pay, rent or services with referral sources Buyers cannot defend pay they cannot benchmark Commission an independent valuation or rent study
Medical director paid with no time records or defined duties Payment without documented work can look like payment for referrals Define duties and start time logs now
Marketing or lead generation fees that vary with patient volume Volume-based pay is a common regulatory diligence flag Convert to a fixed, documented fee
Physician investors in a related ASC, imaging center or lab with unclear distribution formulas Returns that track referrals rather than capital invested draw scrutiny Document the distribution formula and its basis
MSO fee set as a percentage of collections, or MSO control over clinical decisions Buyers flag these for fee-splitting and clinical control questions Restructure the management agreement
Earnout tied to volume from physicians who keep referring to the buyer Payment that rises with referrals draws the closest regulatory scrutiny Propose a metric unrelated to referrals
No enrollment plan for Medicare, Medicaid, commercial payers and state licensing Missed notices or enrollments delay collections after closing Build the plan in the enrollment section below

The management services organizations guide covers how MSO fee and control terms are built. The healthcare deal structures guide explains how MSO models and rollover equity change what the buyer actually acquires.

Structure and Tax: Price Is Not Proceeds

Two offers with the same headline price can leave the seller with very different cash. Structure, price allocation, the working capital peg, malpractice tail, escrow and the non-compete each move the net. Settle them before the LOI, because the LOI usually fixes the structure.

Structure What the buyer gets What the seller faces Where it fits
Asset purchase Chooses the liabilities it assumes and gets a stepped-up tax basis Price is allocated across asset classes, and some classes are taxed as ordinary income. A C corporation seller can face tax at the corporate level and again on distribution Smaller practice deals and buyers that want to leave history behind
Equity purchase Takes the entity with its contracts, enrollments and liabilities Gain on the shares, often taxed as capital gain, though the result depends on entity type, asset character and how the deal is structured Larger deals and entities whose licenses or contracts are hard to move
Pre-closing reorganization (some S corporations) Asset-style tax treatment while buying an entity Owners restructure before closing so the operating company can be sold. Contracts and enrollments can often stay in place, subject to their change-of-control terms S corporation sellers facing a buyer that requires a basis step-up

Purchase price allocation. In an asset sale, the price is allocated across asset classes and both sides report the allocation for tax purposes. Buyers want value in assets they can depreciate quickly. Sellers want it in goodwill. Agree the allocation schedule in the purchase agreement, not after closing, and have your tax adviser confirm how each class is taxed to you.

Worked example: allocation and after-tax proceeds (same group, our arithmetic). The group, a pass-through entity, sells its assets for $20,000,000. This is a simplified illustration, not a generally applicable result. Assumptions, chosen only to show the arithmetic: zero tax basis in goodwill and receivables, fully depreciated equipment, receivables, equipment recapture and non-compete payments all treated as ordinary income at a flat 35%, and goodwill taxed as capital gain at a flat 20%. The 20% rate leaves out any 3.8% net investment income tax and any state income tax, so the real after-tax cost can be higher than shown. Whether receivables produce ordinary income depends on the accounting method and entity type. Actual rates depend on entity, state and the seller's other income.

Allocation A (seller's draft) Allocation B (buyer's draft)
Receivables (ordinary) $2,000,000 $2,000,000
Equipment recapture (ordinary) $1,000,000 $2,000,000
Non-compete (ordinary) $500,000 $1,500,000
Goodwill (capital) $16,500,000 $14,500,000
Total price $20,000,000 $20,000,000
Tax on ordinary items at 35% $3,500,000 × 35% = $1,225,000 $5,500,000 × 35% = $1,925,000
Tax on goodwill at 20% $16,500,000 × 20% = $3,300,000 $14,500,000 × 20% = $2,900,000
Total tax $4,525,000 $4,825,000
After-tax proceeds (before fees, debt and escrow) $15,475,000 $15,175,000

Moving $2,000,000 from goodwill into ordinary classes costs the seller $300,000, which is $2,000,000 × (35% minus 20%). The headline price did not change.

Working capital peg. Most deals set a target level of net working capital the seller must deliver at closing. The price moves dollar for dollar above or below that peg. In practice deals, receivables are often the largest item, and some deals let the seller keep pre-closing receivables and exclude them from the peg. Base the peg on a trailing average from accrual-basis statements, not a single month the buyer picks.

Worked example: peg selection (same group, our arithmetic). The trailing twelve-month average of net working capital is $1,200,000. The seller delivers $1,000,000 at closing, a $200,000 price reduction. If the buyer instead sets the peg at its strongest month, $1,400,000, the same delivery cuts the price by $400,000. The choice of averaging period is worth $200,000 here.

Malpractice tail. A claims-made policy covers only claims reported while it is in force. When it ends at closing, someone buys an extended reporting endorsement (tail) or the buyer's carrier provides prior-acts coverage. Get a tail quote early and settle in the LOI who pays it.

Non-competes. Enforceability varies by state. Keep the scope tied to the market the buyer is paying for, and remember the tax effect of any price allocated to it.

Worked example: from headline price to closing cash (same group, our arithmetic). All amounts are pre-tax. The $20,000,000 headline is the price for the business, and the seller retires its own debt from proceeds.

Line Amount
Headline price ($2,500,000 buyer-basis EBITDA × assumed 8.0x) $20,000,000
Working capital shortfall (peg $1,200,000, delivered $1,000,000) minus $200,000
Debt payoff minus $1,500,000
Seller's transaction fees (assumed, legal, accounting and advisory) minus $600,000
Malpractice tail premium paid by seller (assumed) minus $250,000
Proceeds before escrow $17,450,000
Indemnity escrow held back (assumed 10% of headline price, no RWI) minus $2,000,000
Cash at closing, before tax $15,450,000

The seller receives 77.25% of the headline price at closing in this example ($15,450,000 ÷ $20,000,000). The escrow comes back only to the extent no claims are made against it during the survival period. Run your own numbers in the deal proceeds calculator.

Compare Two LOIs on Net Proceeds

The highest headline price often loses once structure is filled in. This comparison holds debt ($1,500,000), seller fees ($600,000) and tail ($250,000) equal across both offers and assumes the working capital peg is met.

Worked example: two offers (same group, hypothetical terms, our arithmetic, pre-tax).

Line Offer A Offer B
Headline price $20,000,000 $19,000,000
Deferred as earnout (cliff) $3,000,000 $0
Paid at closing before deductions $17,000,000 $19,000,000
Debt, fees and tail minus $2,350,000 minus $2,350,000
Escrow minus $2,000,000 (10% of headline, no RWI) minus $190,000 (1% of headline, with RWI)
Seller's share of RWI policy cost $0 minus $150,000
Cash at closing $12,650,000 $16,310,000
Contingent amounts (earnout plus escrow) $5,000,000 $190,000
Maximum total if every contingent dollar is paid $17,650,000 $16,500,000

Offer B puts $3,660,000 more in the seller's hands at closing, assuming a policy is available on the RWI terms shown, which is not assured at this deal size. Offer A wins by $1,150,000 only if the full earnout is earned and the full escrow is released. Put every LOI through the same table before you choose.

Escrow and Reps and Warranties Insurance

Most private deals hold back part of the price in an indemnification escrow the buyer can claim against if a representation proves wrong. RWI is the term that moves it most. With a policy, the insurer becomes the buyer's main source of recovery above a retention, and the escrow shrinks. Without one, the buyer holds back a larger share for the full survival period.

Worked example: escrow with and without RWI (same $20,000,000 deal, hypothetical terms, our arithmetic).

No RWI With RWI
Escrow held at closing (assumed) $2,000,000 (10%) $200,000 (1%)
Seller's share of policy cost (assumed) $0 $150,000
Cash not available to the seller at closing $2,000,000 $350,000

With a policy, the seller has $1,650,000 more available at closing ($2,000,000 minus $350,000). The escrow can come back later and the premium cannot, so compare the two on the claims you expect. The RWI terms here are assumed for illustration. RWI is less common on physician practice deals of this size, and many close without it. Where a policy is available, the retention, exclusions, pricing and how the buyer recovers under it vary by policy, so treat the With RWI column as one possible outcome, not a typical one.

An RWI insurer reads the buyer's diligence reports before binding a policy and excludes issues already known. A clean QoE, an independent coding audit and a documented compliance record leave fewer areas to exclude. A known problem leads to a special indemnity or a separate escrow sized to the issue, on top of the general holdback.

Earnouts: More Common With PE Buyers in 2025

An earnout pays part of the price later, if the business hits a target after closing. Per SRS Acquiom's 2026 M&A Earnout and Milestone Trends study, U.S. private equity buyers used earnouts in 24% of 2025 deals, up from 13% over 2014 to 2022. U.S. public buyers used them in 18% of 2025 deals, up from 15%. The study covers deals across all industries, not healthcare alone. SRS Acquiom is a deal services vendor and these are its own figures, so treat them as a directional signal.

Buyers propose earnouts when they do not trust the forecast. Verified buyer-basis EBITDA, a clean coding review and spread-out referral relationships take away the usual reasons and give you a stronger case for cash at closing.

Worked example: cliff versus sliding scale (same group, hypothetical terms, our arithmetic). A buyer offers $20,000,000: $17,000,000 at closing and a $3,000,000 earnout if year-one EBITDA reaches $2,700,000, up from the $2,500,000 buyer-basis level.

Year-one EBITDA Cliff earnout (all or nothing) Sliding scale (pro rata from $2,500,000 to $2,700,000)
$2,700,000 $20,000,000 total (100%) $20,000,000 total (100%)
$2,650,000 $17,000,000 total (85%) $17,000,000 + $2,250,000 = $19,250,000 (96.25%)
$2,500,000 $17,000,000 total (85%) $17,000,000 total (85%)

Under the sliding scale, $2,650,000 is 75% of the way from $2,500,000 to $2,700,000, so 75% × $3,000,000 = $2,250,000. Under the cliff, missing the target by $50,000 of EBITDA costs $3,000,000.

Earnout term Ask for Why
Payout shape Sliding scale with a floor Removes the cliff
Metric Revenue or gross profit you control, defined in the agreement The buyer cannot move it through its own cost allocations
Accounting Your historical policies, applied consistently Stops a post-closing change in method from erasing the payout
Acceleration Full payout if the buyer sells the platform or breaches operating covenants Protects you from events you do not control
Referral link A metric unrelated to referral volume from selling physicians Avoids the referral questions covered above

Before you agree to roll equity, work through the physician rollover equity checklist.

Medicare and Payer Enrollment Starts Before Closing

Enrollment is a closing condition in practice, even when the purchase agreement does not call it one. A change of ownership usually means Medicare and Medicaid enrollment work for both the current and incoming owner, and institutional providers such as hospitals, skilled nursing facilities and home health agencies also have a provider agreement to address. The path depends on provider type, deal structure and whether the transaction counts as a reportable change of ownership. Check it against current CMS requirements when you pick the structure, and treat the table below as a general outline, not a rule for your deal.

Seller situation What usually has to happen Planning point
Institutional provider with a provider agreement Change of ownership filings, with the provider agreement transferred or replaced Treat it as pre-closing work with its own timeline
Group practice, equity sale where the entity survives Update the existing enrollment for the new ownership Confirm the reporting window early
Group practice, asset sale New enrollment for the buyer's billing entity and reassignment of each physician's billing rights Budget for a billing gap while enrollments process

Worked example: billing gap (same group, our arithmetic). The group collects $1,000,000 a month ($12,000,000 a year). If new-owner Medicare billing is delayed two months and Medicare is 30% of collections, about $600,000 of cash is deferred ($1,000,000 × 30% × 2). Agree in the purchase agreement who funds that gap and how pre-closing receivables are collected and split.

For every deal:

Build the Data Room Around What Buyers Price

Organize the data room around what a buyer prices: coding, referral arrangements, payer concentration and physician pay. Ask the likely buyer for its diligence request list and map each item to a folder. Give your largest known risk its own labeled folder so nobody can say it was hidden. The healthcare data room checklist has the full folder structure.

A sponsor platform arrives with a long checklist. A family office or physician investor making a first healthcare purchase may ask questions in an unpredictable order. A written Q&A file that answers the obvious questions in advance saves time with both. Buyers read the quality of your risk disclosure as evidence about the company itself.

Core folders:

  1. Corporate. Formation documents, ownership ledger, operating or shareholder agreements, minutes, prior transactions.
  2. Financials. Audited or reviewed statements where available, monthly P&Ls, tax returns, and the sell-side QoE with its workpapers, including the physician compensation model and working capital analysis.
  3. Payer contracts. Every commercial contract with current fee schedules, amendments and termination terms, with change-of-control clauses flagged.
  4. Coding audit. The independent review, sampling method, corrective action and refunds made.
  5. Compliance. Compliance plan, training logs, hotline records, policies and the arrangements inventory.
  6. HR and provider agreements. Employment agreements, restrictive covenants, contractor agreements, benefit plans and credentialing files.
  7. Insurance. Malpractice policies with claims-made or occurrence terms, loss runs and the tail quote.
  8. Real estate. Leases with assignment and change-of-control terms, plus rent studies for related-party property.
  9. IT and privacy. Security risk assessment, business associate agreements, breach and incident log, software contracts and data ownership terms.
  10. Enrollment and licensing. Medicare and Medicaid enrollment records, state facility licenses and the enrollment plan for closing.
  11. Risk register and Q&A. Each known issue, its owner, what was done and what remains, with written answers to the questions your buyer type will ask.

A roll-up platform shows its integration playbook and add-on history. A behavioral health operator puts licensure surveys up front. A health IT company leads with customer retention and security certifications.

Building the Sell-Side Advisory Team and Its Budget

Each step in this guide has an owner outside the practice. Hire them in the order the 12-month sequence below needs their work, and ask each one the screening question before you sign an engagement letter.

Adviser What they produce Engage Screening question before hiring
Healthcare transaction attorney Arrangements review, structure memo, filing map, purchase agreement 12 months before marketing How many sales of practices in our specialty have you closed in the last two years, and on which side?
Independent certified coder Encounter sample by provider, findings, corrective action 10 months before marketing Do you have any relationship with our billing staff or billing vendor?
Sell-side QoE accountant Buyer-basis EBITDA, missing cost lines, working capital analysis, workpapers 9 months before marketing Which buyer-side QoE firms have reviewed your reports, and how far apart did the numbers land?
Tax adviser Structure comparison, draft allocation schedule, after-tax proceeds model 7 months before marketing Can you run both allocations in this guide using our actual tax basis?
Valuation firm Fair market value support for physician pay, rent and medical director fees 6 months before marketing Have your reports been relied on in a buyer's diligence, and what did the buyer question?
Insurance broker Malpractice tail quote, later RWI coordination with the buyer's broker 6 months before marketing What tail and prior-acts options do the likely buyers' carriers offer?
Investment banker or broker Buyer list, marketing materials, competing bids, LOI comparison 3 to 6 months before marketing Which buyers did you bring to your last three healthcare deals, and how many closed at the LOI price? Check the firm and each banker on FINRA BrokerCheck

Worked example: what the fee budget defends (same group, our arithmetic). The proceeds example assumes $600,000 of seller transaction fees, 3.0% of the $20,000,000 headline price ($600,000 ÷ $20,000,000). Set that against the swings this guide has already measured on the same deal:

Swing an adviser team is hired to defend Amount Section
Re-trade from seller-basis to buyer-basis price $6,000,000 Sell-side quality of earnings
Closing cash difference between two LOIs $3,660,000 Compare two LOIs
Closing cash freed by RWI instead of a 10% escrow $1,650,000 Escrow and RWI
After-tax cost of the buyer's allocation draft $300,000 Structure and tax
Peg set on a trailing average instead of the buyer's strongest month $200,000 Structure and tax

The swings overlap and do not add up to a single total, but any one of the three largest is more than the full fee budget. Choose advisers on whether they can defend these numbers, not on the lowest quote.

Your deal attorney also handles transaction notice timing and the question of who may be paid a success fee. The healthcare M&A process guide and the healthcare investment banker guide give background. Take your specific questions on both to your own attorney.

Setting the Closing Date: Workstreams to Start Before the LOI

Filings, consents and enrollments rarely change the price, but they often set the closing date. Map each workstream back from your target closing before you sign the LOI, so exclusivity does not run out while you wait on something you could have started earlier.

Workstream What drives its length Owner Start it
Federal and state transaction notices Deal size, the states involved and the buyer type Seller's and buyer's deal counsel Before the LOI is signed
Medicare, Medicaid and payer enrollment Provider type, deal structure and payer processing A named enrollment lead on each side When the structure is chosen
Payer contract, lease and vendor consents Assignment and change-of-control clauses Seller's administrator While the data room is built
Facility licenses and permits Agency review and any site inspection Seller's operations lead When the structure is chosen
Malpractice tail or prior-acts coverage Carrier quote and the LOI term on who pays Seller's insurance broker Before the LOI is signed
RWI underwriting Completed buyer diligence reports Buyer and its broker After QoE and coding reports are final
Physician employment agreements Agreement on buyer-basis pay Each physician and the buyer Before marketing
Debt payoff and funds flow Payoff letters, lien releases and wire instructions Seller's controller Final weeks before closing

Once an LOI is on the table, settle these points before you agree to a target closing date:

Founder Dependence and Exit Timing

Even with every folder clean, a buyer will discount a business that runs through one person. It prices in the risk that patients, referrers and staff leave once the owner steps back. The test is whether the business could hold its referral flow, payer relationships and schedule for one quarter if you were unavailable. If it could not, move contracting to a manager, spread new patients across other providers and put each referral relationship in more than one name before marketing.

Signal Buyer's read Fix
Founder produces the largest share of collections Revenue walks if the founder slows down Recruit or promote providers and shift new patients to them
Founder personally holds payer negotiations Contract renewals at risk Move contracting to an administrator with a documented history
Top referrers know only the founder Referral flow at risk Introduce a second physician and a practice liaison to each referrer
No one else signs off on finances Reporting depends on one person Monthly close owned by a controller or outsourced CFO

Owners who start late have fewer choices on timing and terms. Decide what you will do after closing before the LOI arrives. A seller with a clear answer can judge employment terms, rollover equity, earnout length, the non-compete and the transition period on their merits.

A 12-Month Preparation Sequence

This sequence follows the priority checklist, counted backward from the month you start marketing. Add any state notice period identified for your deal on top of it.

Months before marketing Work Output
12 Engage healthcare regulatory counsel and list every arrangement with a referral source Arrangements inventory and red-flag list
10 Independent coding review across all billing providers Findings, corrective action, refund log
9 Convert to accrual books, fill missing cost lines and start the sell-side QoE Draft adjusted EBITDA and working capital analysis
8 Agree post-sale W-2 compensation with each physician Buyer-basis EBITDA and physician sign-off
7 Tax structure review: asset versus equity, reorganization options, draft allocation After-tax proceeds model
6 Fix agreements, fair market value support and ownership structure. Get a malpractice tail quote Signed, current documents and tail cost
5 Transfer founder-held relationships and contracting duties Named owners for each referral and payer relationship
4 Confirm federal and state notice requirements and the enrollment path Filing map and timing assumptions
3 Build the data room, risk register and Q&A file Indexed data room
1 Reset the asking price to buyer-basis EBITDA and check it against net proceeds A price you can defend in diligence

Go to Market With Competing Buyers

Preparation pays only if more than one buyer sees it. Approach sponsor platforms, family offices and strategics in parallel. Include hospital systems and regional groups that would buy to keep a competitor out of your market. Healthtech and product companies should run strategics and sponsors side by side and let the bids show whether a strategic premium exists for their business. With several bidders at the table, a diligence finding gets priced in competition. With a single buyer under exclusivity, that buyer uses it to cut the price.

Compare offers on net proceeds, not headline price. Put each LOI through the same model used in the two-offer table above: allocation, peg, escrow, earnout terms and who pays the tail.

Questions Practice Owners and Investors Ask

How much of my sale price will be held back at closing?

Holdbacks are negotiated, and reps and warranties insurance (RWI) moves them more than any other term. With a policy, the insurer is the buyer's main recovery for a breached representation, so the escrow shrinks. Without one, the buyer holds back a larger share of the price for the full survival period. In this guide's hypothetical $20,000,000 deal, a 10% escrow without RWI holds back $2,000,000, against an assumed $350,000 of escrow plus premium share if an RWI policy is available, which is less common at this deal size. Before you count closing cash, subtract any working capital shortfall, debt payoff, fees, malpractice tail premium, escrow and deferred earnout.

Do I need a federal antitrust filing to sell my medical practice or healthcare company?

Federal premerger review mainly reaches larger deals. State healthcare transaction notice laws are a separate question, and a growing number of states apply them to much smaller deals, including physician practice and MSO transactions. Get both checked before you sign the LOI, because either one can set your closing date.

Will a buyer ask for an earnout?

It is more likely than it used to be, especially with private equity. SRS Acquiom's 2026 M&A Earnout and Milestone Trends study, which covers deals across all industries, found earnouts in 24% of 2025 deals by U.S. private equity buyers, up from 13% over 2014 to 2022. U.S. public buyers used them in 18% of 2025 deals, up from 15%. Buyers propose earnouts when they doubt the forecast, so verified earnings and clean coding data give you a stronger case for more cash at closing.

Should I sell assets or equity?

Buyers generally prefer an asset purchase because they choose which liabilities they assume and get a stepped-up tax basis. Sellers often prefer an equity sale because liabilities stay with the entity and more of the gain can receive capital gain treatment. Some S corporation sellers bridge the two with a pre-closing reorganization. The allocation of price across asset classes then decides how much of the gain is taxed as ordinary income. In this guide's hypothetical, moving $2,000,000 from goodwill into ordinary-income classes costs the seller $300,000 at the assumed rates.

Which outpatient specialties are private equity buyers most active in?

Becker's ASC Review, reporting Private Equity Stakeholder Project (PESP) data, counted 148 PE-backed outpatient care deals in calendar 2025, 119 of them add-on acquisitions. Dermatology led with 24 deals, followed by eye care with 22 and oncology with 9. The counts cover PE-backed deals only. Hospital system purchases, other strategic buyers and physician-to-physician sales are outside them.

Sources